Blockchain Registration Transaction Record

Shorepower Merges with Aeternum Health, Pivots to Longevity Peptide Platform

Shorepower Technologies merges with Aeternum Health, transitions from transportation electrification to peptide-based longevity platform with new CEO Paul E. Mann.

This merger represents a significant development in the rapidly evolving longevity and anti-aging industry, marking the entry of a new publicly-traded company specifically focused on peptide-based health optimization. For investors, it creates exposure to the growing $610 billion global wellness market through a company with experienced leadership and proprietary technology. For consumers, it signals more research and potential products in the promising field of peptide therapies for aging, which could eventually lead to accessible interventions for healthspan extension. The transition also demonstrates how traditional companies are pivoting to capitalize on emerging health technologies, potentially accelerating innovation in longevity science. The involvement of Paul Mann, with his extensive biotechnology and investment background, suggests serious scientific and commercial potential behind the peptide technology being transferred.